Application 071437
- Type
- ANDA
- Sponsor
- PAR PHARM
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | DOXEPIN HYDROCHLORIDE | DOXEPIN HYDROCHLORIDE | CAPSULE;ORAL | EQ 25MG BASE | No | No |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2019-07-19 19:46 UTC | 2019-07 | A071437-001 | DOXEPIN HYDROCHLORIDE | EQ 25MG BASE | CAPSULE / ORAL | AB | 1987-11-09 | ea99ee380514… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2019-07-19 19:46 UTC | 2019-07 | A071437-001 | AB | 1 | ea99ee380514… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Doxepin Hydrochloride | DOXEPIN HYDROCHLORIDE | Appco Pharma LLC | abf4c515-8888-4733-80a0-fd4e1cdb84a2 | 2021-04-29 | Boxed warning, Warnings, Adverse reactions | Doxepin Hydrochloride DOXEPIN HYDROCHLORIDE |
| Doxepin Hydrochloride | DOXEPIN HYDROCHLORIDE | Proficient Rx LP | e98f371e-f7fe-4c8f-9491-6eb4c53d43ad | 2021-02-01 | Boxed warning, Warnings, Adverse reactions | Doxepin Hydrochloride DOXEPIN HYDROCHLORIDE |
| Doxepin Hydrochloride | DOXEPIN HYDROCHLORIDE | Contract Pharmacal Corp. | abbf7078-a012-4e1a-e053-2995a90a792d | 2020-08-06 | Boxed warning, Warnings, Adverse reactions | Doxepin Hydrochloride DOXEPIN HYDROCHLORIDE |
| Doxepin Hydrochloride | DOXEPIN HYDROCHLORIDE | Aphena Pharma Solutions - Tennessee, LLC | 10d9eba6-30d1-448a-8d92-a1a02df03303 | 2017-09-05 | Boxed warning, Warnings, Adverse reactions | Doxepin Hydrochloride DOXEPIN HYDROCHLORIDE |
| PRUDOXIN | DOXEPIN HYDROCHLORIDE | Mylan Pharmaceuticals Inc. | ca53346b-8ab3-4722-98f6-cf272706d3fa | 2017-06-29 | Warnings, Adverse reactions | DOXEPIN HYDROCHLORIDE |
| Zonalon | DOXEPIN HYDROCHLORIDE | Mylan Pharmaceuticals Inc. | 5f302247-525e-4acc-852b-00eb1d79af4b | 2017-06-14 | Warnings, Adverse reactions | DOXEPIN HYDROCHLORIDE |
| Doxepin Hydrochloride | DOXEPIN HYDROCHLORIDE | Mylan Pharmaceuticals Inc. | b4771ea7-c19b-4182-bb23-c1473ab583fa | 2017-05-24 | Warnings, Adverse reactions | Doxepin Hydrochloride DOXEPIN HYDROCHLORIDE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.